carbapenems has been researched along with Extravascular Hemolysis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cao, J; Li, W; Shi, S; Wang, L; Yao, Z; Zhang, X; Zhang, Y; Zheng, X; Zhou, T | 1 |
Cao, J; Han, Y; Huang, Z; Kong, J; Wang, Y; Zhang, X; Zhou, C; Zhou, H; Zhou, T | 1 |
Chen, JW; Chia, JS; Chuang, YC; Hsu, CC; Huang, TY; Jung, CJ; Kuo, YM; Liao, YD | 1 |
Aung, TT; Beuerman, RW; Caroline, V; Chew, YS; Koh, JJ; Lakshminarayanan, R; Li, J; Lin, H; Liu, S; Pang, LM; Tan, AL; Tan, DT; Verma, C | 1 |
Arora, R; Chawla, R; Goel, R; Narula, A; Sharma, RK; Thakur, P | 1 |
Dahdouh, E; Daoud, Z; Hajjar, M; Suarez, M | 1 |
6 other study(ies) available for carbapenems and Extravascular Hemolysis
Article | Year |
---|---|
Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimicrobial Peptides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Hemolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moths; Tumor Necrosis Factor-alpha | 2022 |
Octominin: An antimicrobial peptide with antibacterial and anti-inflammatory activity against carbapenem-resistant Escherichia coli both in vitro and in vivo.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimicrobial Peptides; Carbapenems; Cytokines; Escherichia coli; Hemolysis; Humans; Ions | 2023 |
Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Carbapenems; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Design; Drug Resistance, Multiple, Bacterial; Hemolysis; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Pneumonia; Pore Forming Cytotoxic Proteins; Stem Cells | 2021 |
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cell Membrane; Cell Survival; Drug Resistance, Bacterial; Enterobacteriaceae; Fatty Acids; Female; Fibroblasts; Gram-Negative Bacteria; Hemolysis; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Lipopeptides; Lipopolysaccharides; Male; Mice; Microbial Sensitivity Tests; Permeability; Rabbits | 2015 |
Anti-hemolytic, hemagglutination inhibition and bacterial membrane disruptive properties of selected herbal extracts attenuate virulence of Carbapenem Resistant Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cell Membrane; Erythrocytes; Escherichia coli; Flow Cytometry; Hemagglutination; Hemoglobins; Hemolysis; Humans; Microbial Sensitivity Tests; Plant Extracts; Rats; Spectrophotometry; Virulence | 2016 |
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Hemolysis; Humans; Lebanon; Microbial Sensitivity Tests; Peptide Hydrolases; Phenotype; Polymerase Chain Reaction; Siderophores; Virulence; Virulence Factors | 2016 |